OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Legal Officer Todd Anderman sold $87K of Ocular Therapeutix, Inc.
Sold$87,363
$7.29Price
11,984Shares
−8%Stake
What OCUL did after the filing
- The stock from Wed, Oct 14 open, $7.14
- −9.0%
- S&P 500, same days
- −1.9%
7 of 30 trading days so far, to the Oct 23 close.
Traded Thu, Oct 8. Filed Tue, Oct 13, 5:01 PM ET, after the close. Returns use the Oct 14 open and the Oct 23 close. Not investment advice.